Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2003
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368287A1 Process for a homogeneously catalyzed c-c coupling reaction
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/10/2003EP1198455B1 Process for preparing 1-(6-methylpyridin-3-yl)-2- (4-(methylsulphonyl) phenyl] ethanone
12/10/2003EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety
12/10/2003EP1058687B1 Nucleosides
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1461305A 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides useful as fungicides
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1461291A Method for isomerisation of alcohols
12/10/2003CN1460676A Method for synthesizing pasiniazide
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/09/2003US6661559 Electrochromic media for producing a preselected color and devices comprising same
12/09/2003US6660885 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660821 Capable of various polymerization such as radical polymerization, cationic polymerization, anion polymerization and metallocene catalyzed polymerization due to the resonance effect of phenyl group and changing characteristics
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660755 Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
12/09/2003US6660753 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003CA2123697C Novel substituted salicylic acids
12/04/2003WO2003099959A1 Method for producing highly pure tris-ortho metalated organoiridium compounds
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/04/2003WO2003099791A1 Method for producing 4-haloalkyl nicotinic acid amides
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099276A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003072062A3 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/04/2003WO2003066604A3 Novel aryl- and heteroarylpiperazines
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle
12/04/2003WO2002065977A3 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
12/04/2003US20030225287 Synthesis of chiral 2-alkyl amino acids
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225274 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225149 Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
12/04/2003US20030225144 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders
12/04/2003US20030225143 A nicotinate salt of amlodipine, used as hypotensive agents, antiischemic agents; stability, water solubility
12/04/2003US20030225115 Anticoagulants
12/04/2003US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
12/04/2003US20030225099 E.g., 1-(phenylethyl)-(2-(6-(2-pyridin-2-ylethylcarbamoyl)-pyridin-2 -yl)benzyl)carbamate; use as antiarrhythmic active compounds
12/04/2003US20030225089 Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225085 For reducing neuronal cell death in response to a traumatic event
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224941 Uracil substituted phenyl sulfamoyl carboxamides
12/04/2003US20030224940 Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
12/04/2003US20030224300 Photographic processing composition containing heterocycle combination and method of forming image
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2484288A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/03/2003EP1367054A1 Heterocyclic factor Xa inhibitors
12/03/2003EP1367053A1 Process for producing optically active n-aryl-1-amino-2-propanol derivatives
12/03/2003EP1366122A1 Azo dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles, and in the dyeing or printing of hydrophobic fibre materials
12/03/2003EP1366043A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
12/03/2003EP1366016A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1366008A2 Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds
12/03/2003EP1365762A1 Method for increasing leptin levels using nicotinic acid compounds
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1460099A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/03/2003CN1459447A Pyridine derivatives, its preparing process and use as herbicide intermediate
12/03/2003CN1129581C Cyanophenyl derivatives
12/03/2003CN1129579C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
12/02/2003US6657093 Preparation of substituted aromatic compounds
12/02/2003US6657086 For reducing weight in mammals; preventing and treating obesity
12/02/2003US6657063 Combinations of β3 agonists and growth hormone secretagogues
12/02/2003US6657026 Polymerization catalysts
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656958 Substituted pyridine compounds useful for controlling chemical synaptic transmission
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656558 High temperature resistant masking devices with tabs
12/02/2003US6656328 Process for preparation of polyhydric alcohols
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
12/02/2003CA2193705C Merocyanine dye protein stains
11/2003
11/27/2003WO2003097636A1 Novel compounds and their use
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 633